Compound Detail
CHEMBL186113
GW-328267 Phase I
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Phase I
CCn1nnc([C@H]2O[C@@H](n3cnc4c(N)nc(N[C@H](CO)Cc5ccccc5)nc43)[C@H](O)[C@@H]2O)n1
Basic Information
| ChEMBL ID | CHEMBL186113 |
| Name | GW-328267 |
| Phase | Phase I |
| Structure Type | MOL |
| InChI Key | FLBKPDIBGNWXMT-NIQZGXKPSA-N |
7
Targets
31
Activities
4
Assay Types
0
PK Parameters
20
Publications
4
Known Names
1
Indications
Molecular Properties
482.5
MW (Da)
-0.58
ALogP
14
HBA
5
HBD
195.2
PSA (Ų)
0.21
QED
1
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Indications
Acute Lung Injury
Activity Summary
EC50 15 meas. best 9.0
Ki 11 meas. best 8.64
IC50 4 meas. best 9.4
Kd 1 meas. best 8.3
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Adenosine receptor A2a CHEMBL251 | IC50 | 9.4 | 9.4 | 0.4 | 1 |
| Adenosine receptor A2a CHEMBL251 | EC50 | 9.0 | 8.37 | 1.0 | 3 |
| PBMC CHEMBL613107 | IC50 | 8.89 | 8.715 | 1.3 | 2 |
| Adenosine receptor A2a CHEMBL251 | Ki | 8.64 | 7.78 | 2.3 | 4 |
| Adenosine receptor A3 CHEMBL256 | EC50 | 8.38 | 8.38 | 4.2 | 1 |
| Adenosine receptor A3 CHEMBL256 | IC50 | 8.3 | 8.3 | 5.0 | 1 |
| Adenosine receptor A3 CHEMBL256 | Kd | 8.3 | 8.3 | 5.0 | 1 |
| Adenosine receptor A2a CHEMBL302 | EC50 | 8.0 | 8.0 | 10.0 | 2 |
| Adenosine receptor A3 CHEMBL256 | Ki | 7.8 | 7.2933 | 16.0 | 3 |
| Adenosine receptor A2b CHEMBL255 | EC50 | 7.29 | 6.3 | 51.0 | 4 |
| Adenosine receptor A1 CHEMBL226 | Ki | 6.43 | 6.2867 | 369.0 | 3 |
| Adenosine receptor A1 CHEMBL226 | EC50 | 6.05 | 6.05 | 882.0 | 1 |
| Adenosine receptor A2b CHEMBL255 | Ki | 5.89 | 5.89 | 1300.0 | 1 |
| Cavia porcellus CHEMBL369 | EC50 | 4.34 | 4.22 | 46000.0 | 4 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine